Jl Pasquali
1 Papers
Jl Pasquali is an academic researcher. The author has contributed to research in topics: Infliximab & Adalimumab. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients
H. Vallet,Sophie Rivière,Alice Sanna,Alban Deroux,Guillaume Moulis,Olga Addimanda,Carlo Salvarani,Marc Lambert,Philip Bielefeld,Pascal Sève,Jean Sibilia,Jl Pasquali,J.B. Fraison,Isabelle Marie,Laurent Perard,L. Bouillet,F. Cohen,Damien Sène,Yoland Schoindre,O Lidove,P. Le Hoang,Eric Hachulla,Olivier Fain,Xavier Mariette,Thomas Papo,Bertrand Wechsler,Bahram Bodaghi,M. Resche Rigon,Patrice Cacoub,D. Saadoun +29 more
TL;DR: Anti-TNF alpha therapy is efficient in all severe and refractory BD manifestations and appears to be similar regardless of the anti-T NF agent used (infliximab or adalimumab).
199